Advertisement

How Basic Knowledge of the Cell Cycle Has Helped Us Treat Cancer Patients

  • Emil FreiIII

Abstract

While empiricism has, in the past, prominently influenced therapeutic research generally and therapeutic research in cancer specifically, knowledge derived from basic and bridging sciences is increasingly impacting on such research. For cancer, such sciences include particularly pharmacology, immunology, and cytokinetics. The purpose of this presentation is to describe the impact of cytokinetics on therapeutic research in cancer. Increasing knowledge of the cytokinetic behavior of tumors and target normal tissues, and of the effect of various chemotherapeutic agents on aspects of the cell cycle have provided increasingly important therapeutic leads for extrapolation to the clinic. With advances in methodology, it has become increasingly possible to conduct selected cytokinetic studies in parallel with clinical trials.

Keywords

Antitumor Agent Tritiated Thymidine Growth Fraction Mitotic Cycle Nitrogen Mustard 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., DeLena, M., Tancini, G., Bajetta, E., Musemuci, R., and Veronesi, U., 1976, Combination chemotherapy as an adjuvant treatment in operable breast cancer, New Engl. J. Med. 294: 405.CrossRefGoogle Scholar
  2. DeVita, V., Serpick, A., and Carbone, P., 1970, Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann. Intern. Med. 73: 881.Google Scholar
  3. Frei III, E., 1972, Combination cancer chemotherapy, Cancer Res. 32: 2593.Google Scholar
  4. Frei III, E., Whang, J., Scoggins, R. B., Van Scott, E.J., Rail, D. P., and Ben, M., 1964, The stathmokinetic effect of vincristine, Cancer Res. 24: 1918.Google Scholar
  5. Jaffe, N., Frei EI, E., Traggis, D., and Bishop, Y., 1974, Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma, New Engl. J. Med. 291: 994.CrossRefGoogle Scholar
  6. Mendelsohn, M. L., 1962, Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse. III. Growth fraction, J. Natl. Cancer Inst. 28: 1015.Google Scholar
  7. Quastler, H., and Sherman, F. G., 1959, Cell population kinetics in the intesti¬nal epithelium of the mouse, Exp. Cell Res. 17: 420.CrossRefGoogle Scholar
  8. Shirakawa, S., Luce, J. K., Tannock, I., and Frei III, E., 1970. Cell proliferation in human melanoma, J. Clin. Invest. 49: 1188.CrossRefGoogle Scholar
  9. Simpson-Herren, H. E., Lloyd, H., 1970, Kinetic parameters and growth curves for experimental tumor systems, Cancer Chemother. Rep. 54: 143.Google Scholar
  10. Skipper, H. E., and Schabel, F. M., Jr., 1973, Quantitative and cytokinetic studies in experimental tumor models, in: Cancer Medicine ( J. Holland and E. Frei III, eds.), pp. 629 - 650, Lea & Febiger, Philadelphia.Google Scholar
  11. Vadlamudi, S., and Goldin, A., 1971, Influence of mitotic cycle inhibitors in the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210, Cancer Chemother. Rep. 55: 547.Google Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • Emil FreiIII
    • 1
  1. 1.Sidney Farber Cancer InstituteBostonUSA

Personalised recommendations